TWO NEW PROGNOSTIC MARKERS OF MUCOSAL HEALING IN PATIENTS TREATED WITH ANTI-TNF FOR ULCERATIVE COLITIS: THE NEUTROPHIL-TO-LYMPHOCYTE-RATIO AND THE PLATELET-TO-LYMPHOCYTE-RATIODIGESTIVE AND LIVER DISEASEIF3.82019-03-011PREAI
Delivery of doxorubicin across the blood-brain barrier by ondansetron pretreatment: a study in vitro and in vivoCANCER LETTERSIF10.12014-10-0122PREAI
Effect of the drug transporters ABCB1, ABCC2, and ABCG2 on the disposition and brain accumulation of the taxane analog BMS-275,183INVESTIGATIONAL NEW DRUGSIF2.72014-07-3111PREAI
Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancerFUTURE ONCOLOGYIF2.62014-06-1941OAAI
Effect of the drug transporters ABCG2, Abcg2, ABCB1 and ABCC2 on the disposition, brain accumulation and myelotoxicity of the aurora kinase B inhibitor barasertib and its more active form barasertib-hydroxy-QPAINVESTIGATIONAL NEW DRUGSIF2.72013-10-0120PREAI
Abcc4 Together with Abcb1 and Abcg2 Form a Robust Cooperative Drug Efflux System That Restricts the Brain Entry of Camptothecin AnaloguesCLINICAL CANCER RESEARCHIF10.22013-04-1544OAAI
Baseline Inflammatory Status Defined by Neutrophil to Lymphocyte Cell Count Ratio (NLR) Predicts Progression Free Survival (PFS) in Metastatic Colorectal Cancer Patients (mCRC) Undergoing Bevacizumab Based BiochemotherapyEUROPEAN JOURNAL OF CANCERIF7.12011-09-016PREAI
Treatment-related Changes in Systemic Inflammatory Status, Measured by Neutrophil-to-lymphocyte Ratio, is Predictive of Outcome in Metastatic Colorectal Cancer PatientsEUROPEAN JOURNAL OF CANCERIF7.12011-09-014PREAI
Mitochondrial Expression and Functional Activity of Breast Cancer Resistance Protein in Different Multiple Drug-Resistant Cell LinesCANCER RESEARCHIF16.62009-09-1462OAAI
Vitamin E protects DNA from oxidative damage in human hepatocellular carcinoma cell linesFREE RADICAL RESEARCHIF2.92009-07-0726PREAI
Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type miceMOLECULAR CANCER THERAPEUTICSIF5.52008-08-21191PREAI
Hepatocellular carcinoma: Epidemiology and clinical aspectsMOLECULAR ASPECTS OF MEDICINEIF10.32008-02-0198PREAI
In vitro transport of gimatecan (7-t-butoxyiminomethylcamptothecin) by breast cancer resistance protein, P-glycoprotein, and multidrug resistance protein 2MOLECULAR CANCER THERAPEUTICSIF5.52007-12-1835PREAI
P-gp localization in mitochondria and its functional characterization in multiple drug-resistant cell linesEXPERIMENTAL CELL RESEARCHIF3.52006-12-0178PREAI
Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosisCLINICAL GASTROENTEROLOGY AND HEPATOLOGYIF122006-11-0111OAAI
Differential expression proteomics of human colon cancerAMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGYIF3.32006-06-0169PREAI
Coordination of nuclear- and mitochondrial-DNA encoded proteins in cancer and normal colon tissuesBIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICSIF2.72006-05-0120PRE
Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines肝细胞生长因子和诱导型一氧化氮合酶参与多药耐药诱导的肝癌细胞系血管生成CANCER RESEARCHIF16.62006-03-0155PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向